Published in Prim Care Companion J Clin Psychiatry on December 01, 2001
Prevalence and comorbidity of psychiatric diagnoses based on reference standard in an HIV+ patient population. Psychosom Med (2008) 1.19
Assessment of depression and anxiety in adult cancer outpatients: a cross-sectional study. BMC Cancer (2010) 1.11
Men's pathways to risky sexual behavior: role of co-occurring childhood sexual abuse, posttraumatic stress disorder, and depression histories. J Urban Health (2005) 1.11
Study of a cohort of patients newly diagnosed with depression in general practice: prevalence, incidence, comorbidity, and treatment patterns. Prim Care Companion J Clin Psychiatry (2010) 1.06
Depression shows divergent effects on evoked and spontaneous pain behaviors in rats. J Pain (2010) 1.03
Prevalence of mental and social disorders in adults attending primary care centers in Bosnia and Herzegovina. Croat Med J (2006) 0.98
The problem of "just for fun": patterns of use situations among active club drug users. Addict Behav (2010) 0.94
Prevalence and associated positive psychological variables of depression and anxiety among Chinese cervical cancer patients: a cross-sectional study. PLoS One (2014) 0.93
The prevalence of depression and anxiety among Chinese adults with cancer: a systematic review and meta-analysis. BMC Cancer (2013) 0.92
Omega-3 polyunsaturated fatty acid (PUFA) status in major depressive disorder with comorbid anxiety disorders. J Clin Psychiatry (2013) 0.86
The potential biomarker panels for identification of Major Depressive Disorder (MDD) patients with and without early life stress (ELS) by metabonomic analysis. PLoS One (2014) 0.85
Health care utilisation in the first year of life among infants of mothers with perinatal depression or anxiety. Paediatr Perinat Epidemiol (2013) 0.83
Patient-reported outcomes of quality of life, functioning, and depressive symptom severity in major depressive disorder comorbid with panic disorder before and after SSRI treatment in the star*d trial. Depress Anxiety (2013) 0.83
Anxiety disorders and physical comorbidity: increased prevalence but reduced relevance of specific risk factors for hospital-based mortality during a 12.5-year observation period in general hospital admissions. Eur Arch Psychiatry Clin Neurosci (2014) 0.83
Chronic non-social stress affects depressive behaviors but not anxiety in mice. Korean J Physiol Pharmacol (2014) 0.82
Depression in primary care, part 1: screening and diagnosis. Malays Fam Physician (2007) 0.81
Characteristics of subjects with comorbidity of symptoms of generalized anxiety and major depressive disorders and the corresponding threshold and subthreshold conditions in an Arab general population sample. Med Sci Monit (2012) 0.80
The Effect of Stress Management Model in Quality of Life in Breast Cancer Women. Iran J Cancer Prev (2015) 0.80
Coexisting anxiety and depressive symptoms in patients with heart failure. Eur J Cardiovasc Nurs (2014) 0.79
5HTTLPR predicts left fusiform gyrus activation to positive emotional stimuli. Magn Reson Imaging (2008) 0.78
Medications for panic disorder and generalized anxiety disorder during pregnancy. Prim Care Companion J Clin Psychiatry (2005) 0.78
The DARE study of relapse prevention in depression: design for a phase 1/2 translational randomised controlled trial involving mindfulness-based cognitive therapy and supported self monitoring. BMC Psychiatry (2012) 0.78
Altered explorative strategies and reactive coping style in the FSL rat model of depression. Front Behav Neurosci (2015) 0.78
Emotional predictors and behavioral triggers of acute coronary syndrome. Cleve Clin J Med (2008) 0.78
Major depression in primary care: making the diagnosis. Singapore Med J (2016) 0.78
Social Networking Sites, Depression, and Anxiety: A Systematic Review. JMIR Ment Health (2016) 0.78
Chronic subordinate colony housing paradigm: a mouse model to characterize the consequences of insufficient glucocorticoid signaling. Front Psychiatry (2015) 0.78
Generalized Anxiety Disorder and Social Anxiety Disorder, but Not Panic Anxiety Disorder, Are Associated with Higher Sensitivity to Learning from Negative Feedback: Behavioral and Computational Investigation. Front Integr Neurosci (2016) 0.77
Behavioral activation for late adolescents with subthreshold depression: a randomized controlled trial. Eur Child Adolesc Psychiatry (2016) 0.77
Nonhuman primate models of depression: effects of early experience and stress. ILAR J (2014) 0.77
Associations of Parent-Child Anxious and Depressive Symptoms When a Caregiver Has a History of Depression. J Child Fam Stud (2010) 0.77
Lipopolysaccharide-Induced Behavioral Alterations Are Alleviated by Sodium Phenylbutyrate via Attenuation of Oxidative Stress and Neuroinflammatory Cascade. Inflammation (2016) 0.76
Psychiatric comorbidity in depressed HIV-infected individuals: common and clinically consequential. Gen Hosp Psychiatry (2015) 0.76
Physical Comorbidities in Depression Co-Occurring with Anxiety: A Cross Sectional Study in the Czech Primary Care System. Int J Environ Res Public Health (2015) 0.76
Correlates of symptoms of depression and anxiety among clinic patients in western Jamaica. West Indian Med J (2013) 0.76
Psychological Disorders and Psychosocial Resources of Patients with Newly Diagnosed Bladder and Kidney Cancer: A Cross-Sectional Study. PLoS One (2016) 0.76
Explaining Sad People's Memory Advantage for Faces. Front Psychol (2017) 0.75
The Role of Neuroticism and Experiential Avoidance in Predicting Anxiety and Depression Symptoms: Mediating Effect of Emotion Regulation. Iran J Psychiatry Behav Sci (2016) 0.75
Anxiety and diabetes: Innovative approaches to management in primary care. Exp Biol Med (Maywood) (2016) 0.75
Depression, anxiety and stress levels in industrial workers: A pilot study in Bangalore, India. Ind Psychiatry J (2015) 0.75
Depression and anxiety behaviour in a rat model of chronic migraine. J Headache Pain (2017) 0.75
Perceived distress and its association with depression and anxiety in breast cancer patients. PLoS One (2017) 0.75
A wavelet-based technique to predict treatment outcome for Major Depressive Disorder. PLoS One (2017) 0.75
Depression and Anxiety in Women During Pregnancy in Slovenia. Zdr Varst (2014) 0.75
Resting state connectivity of the human habenula at ultra-high field. Neuroimage (2016) 0.75
Psychometric properties of an automated telephone-based PHQ-9. Telemed J E Health (2013) 0.75
Psychotherapy and Social Change: Utilizing Principles of Cognitive-Behavioral Therapy to Help Develop New Prejudice-Reduction Interventions. Front Psychol (2015) 0.75
Prevalence of Depression and Associated Factors among Diabetic Patients at Mekelle City, North Ethiopia. Indian J Psychol Med (2017) 0.75
Prevalence of Depression and Anxiety amongst Cancer Patients in a Hospital Setting: A Cross-Sectional Study. Psychiatry J (2016) 0.75
Physical Exercise for Treatment of Mood Disorders: A Critical Review. Curr Behav Neurosci Rep (2016) 0.75
Demographics, Health, and Risk Behaviors of Young Adults Who Drink Energy Drinks and Coffee Beverages. J Caffeine Res (2016) 0.75
Factorial invariance of the Patient Health Questionnaire and Generalized Anxiety Disorder Questionnaire. Br J Clin Psychol (2013) 0.75
Sex differences modulating serotonergic polymorphisms implicated in the mechanistic pathways of risk for depression and related disorders. J Neurosci Res (2017) 0.75
Value-Based Benefit Design to Improve Medication Adherence for Employees with Anxiety or Depression. Am Health Drug Benefits (2015) 0.75
Improving risk prediction for depression via Elastic Net regression - Results from Korea National Health Insurance Services Data. AMIA Annu Symp Proc (2017) 0.75
Diagnosis and Treatment Procedures for Patients With Anxiety Disorders by the Psychiatric Consultation Liaison Service in a General Hospital in Germany: A Retrospective Analysis. Prim Care Companion CNS Disord (2015) 0.75
A Korean validation study of the Clinically Useful Anxiety Outcome Scale: Comorbidity and differentiation of anxiety and depressive disorders. PLoS One (2017) 0.75
An Analysis of Anxiety-Related Postings on Sina Weibo. Int J Environ Res Public Health (2017) 0.75
A positron emission tomography study of the serotonergic system in relation to anxiety in depression. Eur Neuropsychopharmacol (2017) 0.75
Enhanced Risk Aversion, But Not Loss Aversion, in Unmedicated Pathological Anxiety. Biol Psychiatry (2016) 0.75
The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med (2001) 76.04
Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry (1994) 48.75
Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry (1995) 30.84
Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med (2000) 12.83
The de facto US mental and addictive disorders service system. Epidemiologic catchment area prospective 1-year prevalence rates of disorders and services. Arch Gen Psychiatry (1993) 9.09
Depression following myocardial infarction. Impact on 6-month survival. JAMA (1993) 8.64
Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care (2000) 8.63
Depression and 18-month prognosis after myocardial infarction. Circulation (1995) 7.22
The quality of care for depressive and anxiety disorders in the United States. Arch Gen Psychiatry (2001) 6.39
Prescribing trends in psychotropic medications: primary care, psychiatry, and other medical specialties. JAMA (1998) 5.09
Depression, disability days, and days lost from work in a prospective epidemiologic survey. JAMA (1990) 4.70
Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey. Br J Psychiatry Suppl (1996) 3.99
Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial. Biol Psychiatry (1998) 3.27
Somatization and the recognition of depression and anxiety in primary care. Am J Psychiatry (1993) 3.26
Depression and the course of coronary artery disease. Am J Psychiatry (1998) 3.17
Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA (2000) 2.91
Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation (1996) 2.88
Mental disorders and disability among patients in a primary care group practice. Am J Psychiatry (1997) 2.49
The nature and course of depression following myocardial infarction. Arch Intern Med (1989) 2.19
The hidden mental health network. Treatment of mental illness by nonpsychiatrist physicians. Arch Gen Psychiatry (1985) 2.17
Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial. J Clin Psychiatry (2001) 2.17
The effects of non-prescribing of anxiolytics in general practice. I. Controlled evaluation of psychiatric and social outcome. Br J Psychiatry (1984) 2.16
Depression comorbid with anxiety: results from the WHO study on psychological disorders in primary health care. Br J Psychiatry Suppl (1996) 2.14
Distressed high utilizers of medical care. DSM-III-R diagnoses and treatment needs. Gen Hosp Psychiatry (1990) 2.13
Depression and chronic medical illness. J Clin Psychiatry (1990) 2.10
Headache and major depression: is the association specific to migraine? Neurology (2000) 1.91
Pharmacokinetics of selective serotonin reuptake inhibitors. Pharmacol Ther (2000) 1.87
Use of the Nottingham Health Profile with patients after a stroke. J Epidemiol Community Health (1986) 1.86
Development and validation of the SDDS-PC screen for multiple mental disorders in primary care. Arch Fam Med (1995) 1.75
Change in depression as a precursor of cardiovascular events. SHEP Cooperative Research Group (Systoloc Hypertension in the elderly). Arch Intern Med (1996) 1.72
Prevalence, clinical manifestations, etiology, and treatment of depression in Parkinson's disease. J Neuropsychiatry Clin Neurosci (2001) 1.70
types of stressful life event and the onset of anxiety and depressive disorders. Psychol Med (1981) 1.68
Lifetime panic-depression comorbidity in the National Comorbidity Survey. Association with symptoms, impairment, course and help-seeking. Br J Psychiatry (2000) 1.68
Treatment outcomes for primary care patients with major depression and lifetime anxiety disorders. Am J Psychiatry (1996) 1.57
Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry (2001) 1.52
Antidepressants in panic disorder. J Clin Psychiatry (1997) 1.51
Lifetime panic-depression comorbidity in the National Comorbidity Survey. Arch Gen Psychiatry (1998) 1.51
Subsyndromal ("mixed") anxiety--depression in primary care. J Gen Intern Med (1994) 1.50
SSRIS versus tricyclic antidepressants in depressed inpatients: a meta-analysis of efficacy and tolerability. Depress Anxiety (1998) 1.44
Clinically relevant pharmacology of selective serotonin reuptake inhibitors. An overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism. Clin Pharmacokinet (1997) 1.40
Interruption of selective serotonin reuptake inhibitor treatment. Double-blind, placebo-controlled trial. Br J Psychiatry (2000) 1.37
Fluoxetine versus sertraline and paroxetine in major depressive disorder: changes in weight with long-term treatment. J Clin Psychiatry (2000) 1.36
Paroxetine: a review. CNS Drug Rev (2001) 1.26
The neuropsychiatry of stroke. Psychosomatics (2000) 1.25
Comorbid anxiety disorder and the functioning and well-being of chronically ill patients of general medical providers. Arch Gen Psychiatry (1996) 1.24
Treatment received by depressed patients. JAMA (1982) 1.14
Depression and coronary heart disease: a review for cardiologists. Clin Cardiol (1997) 1.10
Depression and panic attacks: the significance of overlap as reflected in follow-up and family study data. Am J Psychiatry (1988) 1.08
Depression in patients with coronary artery disease. Depression (1996) 1.05
Depression in the medical setting: biopsychological interactions and treatment considerations. J Clin Psychiatry (1999) 1.02
Depression in a primary care clinic: the prevalence and impact of an unrecognized disorder. J Affect Disord (1999) 1.02
Cytochrome P450 enzymes: interpretation of their interactions with selective serotonin reuptake inhibitors. Part II. J Clin Psychopharmacol (1996) 1.01
A ten-year review of the validity and clinical utility of depression screening. Psychiatr Serv (1998) 1.01
Guidelines for the clinical use of benzodiazepines: pharmacokinetics, dependency, rebound and withdrawal. Canadian Society for Clinical Pharmacology. Can J Clin Pharmacol (1999) 0.99
Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression. J Affect Disord (2000) 0.96
Suicide attempts in patients with panic disorder. Arch Gen Psychiatry (1993) 0.94
Depression in Adults with Diabetes. Semin Clin Neuropsychiatry (1997) 0.92
Efficacy of venlafaxine extended release in patients with major depressive disorder and comorbid generalized anxiety disorder. J Clin Psychiatry (2001) 0.89
Depression following myocardial infarction. Int J Psychiatry Med (1992) 0.89
Pharmacokinetic drug interactions of new antidepressants: a review of the effects on the metabolism of other drugs. Mayo Clin Proc (1997) 0.87
Incidence of antidepressant drug use in older adults and association with chronic diseases: the Rotterdam Study. Int Clin Psychopharmacol (1997) 0.87
Multicenter double-blind comparison of sertraline and desipramine for concurrent obsessive-compulsive and major depressive disorders. Arch Gen Psychiatry (2000) 0.85
Management of sexual side effects of antidepressant therapy. J Clin Psychiatry (1999) 0.84
Problems with tricyclic antidepressant use in patients with panic disorder or agoraphobia: results of a naturalistic follow-up study. J Clin Psychiatry (1989) 0.83
Diabetes mellitus and major depressive disorder: an overview of prevalence, complications, and treatment. Depress Anxiety (1998) 0.82
Effect on sexual function of long-term treatment with selective serotonin reuptake inhibitors in depressed patients treated in primary care. J Clin Psychopharmacol (2001) 0.82
Prodromes of depression and anxiety. The Stirling County study. Br J Psychiatry (1989) 0.80
Sexual dysfunction in depression: disease- or drug-related? Depress Anxiety (1998) 0.80
Do benzodiazepines cause depression? Hosp Community Psychiatry (1991) 0.79
Psychiatric disorder in a rural and an urban population: 3. Social integration and the morphology of affective disorder. Psychol Med (1984) 0.78
Influence of depression on the treatment of panic disorder with imipramine, alprazolam and placebo. J Affect Disord (1993) 0.77
Vulnerability factors and depression. Br J Psychiatry (1981) 0.77
From the Bench to the Trench: A Comparison of Sertraline Treatment of Major Depression in Clinical and Research Patient Samples. Prim Care Companion J Clin Psychiatry (1999) 0.77